Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Stephan Brönimann

Nonmuscle Invasive Urothelial Cancer— Bacillus Calmette–Guérin Instillation or Checkpoint Inhibitor Immunotherapy?

Memo - Magazine of European Medical Oncology

Oncology

Hematology

2019

English

Related publications

Bacillus Calmette–Guerin Immunotherapy for Urothelial Carcinoma of the Bladder

English

The Effect of Restaging Transurethral Resection on Recurrence and Progression Rates in Patients With Nonmuscle Invasive Bladder Cancer Treated With Intravesical Bacillus Calmette-Guérin

Journal of Urology

Urology

2014

English

Autologous Tumor Lysate/Bacillus Calmette–Guérin Immunotherapy as an Adjuvant to Conventional Breast Cancer Therapy

Clinical and Translational Oncology

English

Poncet’s Disease After the Intravesical Instillation of Bacillus Calmette–Guérin (BCG): A Case Report

English

Bacillus Calmette–Guérin‐unresponsive Non‐muscle‐invasive Bladder Cancer: Its Definition and Future Therapeutic Strategies

International Journal of Urology

Urology

2019

English

SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients With Nonmuscle Invasive Bladder Cancer and Recurrence After 2 Prior Courses of Intravesical Bacillus Calmette-Guérin

Journal of Urology

Urology

2013

English

Association Between Metabolic Syndrome and Recurrences of Non-Muscle Invasive Bladder Cancer Following Bacillus Calmette-Guérin Treatment

Urology Practice

Urology

2018

English

Erratum To: Autologous Tumor Lysate/Bacillus Calmette–Guérin Immunotherapy as an Adjuvant to Conventional Breast Cancer Therapy

Clinical and Translational Oncology

English

Effectiveness of Transurethral Resection Under the Control of Photodynamic Diagnosis and Intravesical Instillation of Bacillus Calmette–Guérin in Case of Poorly Differentiated Non-Muscle-Invasive Bladder Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Stephan Brönimann

Nonmuscle Invasive Urothelial Cancer— Bacillus Calmette–Guérin Instillation or Checkpoint Inhibitor Immunotherapy?

Related publications

Bacillus Calmette–Guerin Immunotherapy for Urothelial Carcinoma of the Bladder

The Effect of Restaging Transurethral Resection on Recurrence and Progression Rates in Patients With Nonmuscle Invasive Bladder Cancer Treated With Intravesical Bacillus Calmette-Guérin

Autologous Tumor Lysate/Bacillus Calmette–Guérin Immunotherapy as an Adjuvant to Conventional Breast Cancer Therapy

Poncet’s Disease After the Intravesical Instillation of Bacillus Calmette–Guérin (BCG): A Case Report

Bacillus Calmette–Guérin‐unresponsive Non‐muscle‐invasive Bladder Cancer: Its Definition and Future Therapeutic Strategies

SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients With Nonmuscle Invasive Bladder Cancer and Recurrence After 2 Prior Courses of Intravesical Bacillus Calmette-Guérin

Association Between Metabolic Syndrome and Recurrences of Non-Muscle Invasive Bladder Cancer Following Bacillus Calmette-Guérin Treatment

Erratum To: Autologous Tumor Lysate/Bacillus Calmette–Guérin Immunotherapy as an Adjuvant to Conventional Breast Cancer Therapy

Effectiveness of Transurethral Resection Under the Control of Photodynamic Diagnosis and Intravesical Instillation of Bacillus Calmette–Guérin in Case of Poorly Differentiated Non-Muscle-Invasive Bladder Cancer